{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:27:21Z","timestamp":1779377241617,"version":"3.53.1"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p><jats:italic>ACAN<\/jats:italic> gene variants are an important cause of familial short stature (FSS). Appropriate growth-promoting therapies effectively improve the patient height. Here, we report a therapeutic assessment of cases of seven families of FSS patients with heterozygous <jats:italic>ACAN<\/jats:italic> variants. Our findings provide a valuable theoretical basis for the clinical diagnosis and treatment of this disease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From December 2020 to June 2021, 32 FSS patients were examined in Tianjin Medical University General Hospital (Tianjin, China) by whole-exome sequencing to determine whether <jats:italic>ACAN<\/jats:italic> variants were present. Their clinical data were summarized and scrupulously analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found seven novel heterozygous <jats:italic>ACAN<\/jats:italic> variants: c.1051 + 2T &amp;gt; A, c.313T &amp;gt; C (p.S105P), c.2660C &amp;gt; G (p.S887X), c.2153C &amp;gt; A (p. T718K), c.7243delG (p.D2415Tfs<jats:sup>*<\/jats:sup>4), c.2911G &amp;gt; T (p.G971X), c.758-7T &amp;gt; C. All seven patients had proportionate short stature and mild skeletal dysplasia. Endocrine examination results were normal. Only one of the patients had an advanced bone age (1.1 years older than chronological age), whereas the other patients had normal bone ages. All of them had a family history of short stature, with or without osteoarthritis or intervertebral disc disease. All seven patients accepted treatment with recombinant human growth hormone (rhGH) and were regularly followed up. One patient did not come at the follow-up visit. The height of the remaining six patients before and after the treatment was \u22122.89 \u00b1 0.68 SDS, \u22121.91 \u00b1 0.93 SDS, respectively, with a treatment course of 1.85 \u00b1 1.91 years. A good therapeutic response was observed in all of them.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this study, seven novel heterozygous variants in <jats:italic>ACAN<\/jats:italic> were discovered, which expanded the spectrum of the already established <jats:italic>ACAN<\/jats:italic> pathogenic variants. In FSS cohort, the proportion of <jats:italic>ACAN<\/jats:italic> variants accounted was large. The treatment with rhGH effectively increased the patient height, but further studies with longer follow-up periods and more extensive observations are required to elucidate the long-term effect.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.819074","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T09:17:06Z","timestamp":1646644626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of Growth Hormone Therapy in Seven Chinese Children With Familial Short Stature Caused by Novel ACAN Variants"],"prefix":"10.3389","volume":"10","author":[{"given":"Jie","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/nrendo.2015.165","article-title":"Short and tall stature: a new paradigm emerges","volume":"11","author":"Baron","year":"2015","journal-title":"Nat Rev Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ajhg.2008.12.001","article-title":"A recessive skeletal dysplasia, SEMD aggrecan type, results from a missense mutation affecting the C-type lectin domain of aggrecan","volume":"84","author":"Tompson","year":"2009","journal-title":"Am J Hum Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.cca.2017.04.004","article-title":"Novel pathogenic ACAN variants in non-syndromic short stature patients","volume":"469","author":"Hu","year":"2017","journal-title":"Clin Chim Acta."},{"key":"B4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ydbio.2014.10.005","article-title":"Aggrecan is required for growth plate cytoarchitecture and differentiation","volume":"396","author":"Lauing","year":"2014","journal-title":"Dev Biol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"12225","DOI":"10.1038\/s41598-017-12465-6","article-title":"Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature","volume":"7","author":"Hauer","year":"2017","journal-title":"Sci Rep."},{"key":"B7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1507\/endocrj.EJ17-0150","article-title":"Next generation sequencing-based mutation screening of 86 patients with idiopathic short stature","volume":"64","author":"Hattori","year":"2017","journal-title":"Endocr J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.1210\/jc.2018-02288","article-title":"High prevalence of growth plate gene variants in children with familial short stature treated with GH","volume":"104","author":"Plachy","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2711","DOI":"10.1210\/clinem\/dgab088","article-title":"A high proportion of novel ACAN mutations and their prevalence in a large cohort of Chinese short stature children","volume":"106","author":"Lin","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1210\/jc.2018-01971","article-title":"Multigene sequencing analysis of children born small for gestational age with isolated short stature","volume":"104","author":"Freire","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.4158\/EP-2019-0518","article-title":"Growth-promoting therapies may be useful in short stature patients with nonspecific skeletal abnormalities caused By Acan Heterozygous Mutations: six chinese cases and literature review","volume":"26","author":"Liang","year":"2020","journal-title":"Endocr Pract"},{"key":"B12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1210\/jc.2016-3313","article-title":"Clinical characterization of patients with autosomal dominant short stature due to aggrecan mutations","volume":"102","author":"Gkourogianni","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"E1510","DOI":"10.1210\/jc.2014-1332","article-title":"Short stature, accelerated bone maturation, and early growth cessation due to heterozygous aggrecan mutations","volume":"99","author":"Nilsson","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1515\/jpem-2014-0450","article-title":"Idiopathic short stature due to novel heterozygous mutation of the aggrecan gene","volume":"28","author":"Quintos","year":"2015","journal-title":"J Pediatr Endocrinol Metab."},{"key":"B15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12881-018-0591-z","article-title":"Novel aggrecan variant, p. Gln2364Pro, causes severe familial nonsyndromic adult short stature and poor growth hormone response in Chinese children","volume":"19","author":"Xu","year":"2018","journal-title":"BMC Med Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41439-020-00132-8","article-title":"A novel mutation in the ACAN gene in a family with autosomal dominant short stature and intervertebral disc disease","volume":"7","author":"Uchida","year":"2020","journal-title":"Hum Genome Var."},{"key":"B17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/cen.13581","article-title":"Heterozygous aggrecan variants are associated with short stature and brachydactyly: Description of 16 probands and a review of the literature","volume":"88","author":"Sentchordi-Montan\u00e9","year":"2018","journal-title":"Clin Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1210\/jc.2016-2941","article-title":"ACAN gene mutations in short children born SGA and response to growth hormone treatment","volume":"102","author":"van der Steen","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/jhg.2017.33","article-title":"Identification of a novel heterozygous mutation of the Aggrecan gene in a family with idiopathic short stature and multiple intervertebral disc herniation","volume":"62","author":"Dateki","year":"2017","journal-title":"J Hum Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/EJE-19-0771","article-title":"High frequency of pathogenic ACAN variants including an intragenic deletion in selected individuals with short stature","volume":"182","author":"Stavber","year":"2020","journal-title":"Eur J Endocrinol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.3390\/ijms20236009","article-title":"Growth plate chondrocytes: skeletal development, growth and beyond","volume":"20","author":"Hallett","year":"2019","journal-title":"Int J Mol Sci."}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.819074\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T09:17:08Z","timestamp":1646644628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.819074\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":21,"alternative-id":["10.3389\/fped.2022.819074"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.819074","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"article-number":"819074"}}